Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study
Status:
Recruiting
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
The aim of this clinical trial is to evaluate the effect of low doses of antiplatelet
medications (aspirin 81 mg/day or clopidogrel 75 mg/day) with or without a combination of
antioxidants (N-acetylcysteine 600 mg/day) in a dry AMD patient with large drusen.
Participants will divided in to three groups.
- Participants who were already taking low dose antiplatelet medications.
- Participants who take the antiplatelet drug mentioned above in addition to the
antioxidant prescribed by the investigator
- Participants does not use any medications.